Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check5 days agoChange DetectedA new entry was added to the Study Record Versions list. The rest of the page content remains unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference11%

- Check41 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check55 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1) and the 'Back to Top' link was removed—a version bump with a minor UI change.SummaryDifference0.7%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.7%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference22%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.